Presently, two pathological hallmarks of AD, amyloid plaques and tangles (which were formed by amyloid‐β, Aβ, and tau), can be visualized by positron emission tomography (PET), and Aβ or tau levels in cerebrospinal fluid (CSF) and plasma can be measured.1 The gene discussed is MAPT; the disease is Alzheimer disease.